Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MPI | P34949 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
| ▸ | LPL | P06858 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20102233 | 0.97 | PDK2 (0.32) | PDK2GPR84CYP11B1KDM4EMEN1 | |
| SCHEMBL20102239 | 0.96 | LPL (0.32) | PDK2GPR84CYP11B1LPLLIPG | |
| SCHEMBL20102230 | 0.96 | LPL (0.34) | PDK2GPR84CYP11B1LPLLIPG | |
| SCHEMBL20102224 | 0.96 | LPL (0.34) | PDK2GPR84CYP11B1LPLLIPG | |
| SCHEMBL17243518 | 0.95 | GPR84 (0.33) | PDK2GPR84CYP11B1KDM4EMEN1 | |
| SCHEMBL20102240 | 0.95 | LPL (0.31) | PDK2GPR84CYP11B1LPLLIPG | |
| SCHEMBL10034404 | 0.95 | PDK2 (0.37) | PDK2GPR84CYP11B1KDM4EMEN1 | |
| SCHEMBL20102231 | 0.95 | PDK2 (0.37) | PDK2GPR84CYP11B1KDM4EMEN1 | |
| SCHEMBL10034410 | 0.95 | PDK2 (0.37) | PDK2GPR84CYP11B1KDM4EMEN1 | |
| SCHEMBL23448090 | 0.94 | CYP11B1 (0.35) | PDK2GPR84CYP11B1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180123042-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| US-20180123042-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123042-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | OR10J3, BMI1, ETV6 | PDK2 2148/4885GPR84 3448/4885CYP11B1 1121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.